Bank of Montreal Can Sells 137,262 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Bank of Montreal Can lowered its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 16.3% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 702,500 shares of the medical equipment provider's stock after selling 137,262 shares during the period. Bank of Montreal Can owned 0.20% of Intuitive Surgical worth $366,677,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in ISRG. Atala Financial Inc bought a new position in shares of Intuitive Surgical in the 4th quarter valued at approximately $25,000. Hurley Capital LLC acquired a new position in Intuitive Surgical during the fourth quarter valued at approximately $28,000. Berbice Capital Management LLC bought a new position in shares of Intuitive Surgical in the fourth quarter valued at approximately $26,000. BankPlus Trust Department acquired a new stake in shares of Intuitive Surgical in the fourth quarter worth $28,000. Finally, Summit Securities Group LLC bought a new stake in shares of Intuitive Surgical during the 4th quarter worth $30,000. Institutional investors own 83.64% of the company's stock.

Insiders Place Their Bets

In other news, CFO Jamie Samath sold 94 shares of the business's stock in a transaction on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total transaction of $53,684.34. Following the completion of the sale, the chief financial officer now owns 2,630 shares in the company, valued at $1,502,019.30. The trade was a 3.45 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Amal M. Johnson sold 4,635 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the sale, the director now owns 12,275 shares of the company's stock, valued at approximately $6,955,015. This represents a 27.41 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 33,754 shares of company stock valued at $17,691,621. 0.70% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on ISRG. Evercore ISI upped their price target on shares of Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. CICC Research started coverage on Intuitive Surgical in a report on Monday, January 27th. They issued a "neutral" rating and a $550.00 target price on the stock. Raymond James upped their price target on Intuitive Surgical from $560.00 to $688.00 and gave the stock an "outperform" rating in a report on Friday, January 24th. JPMorgan Chase & Co. increased their price objective on Intuitive Surgical from $575.00 to $675.00 and gave the company an "overweight" rating in a research report on Friday, January 24th. Finally, Jefferies Financial Group boosted their target price on shares of Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have given a buy rating to the company's stock. Based on data from MarketBeat.com, Intuitive Surgical has a consensus rating of "Moderate Buy" and an average target price of $611.86.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG traded up $4.08 on Friday, hitting $493.60. The stock had a trading volume of 2,842,153 shares, compared to its average volume of 1,599,856. The company has a market capitalization of $175.81 billion, a price-to-earnings ratio of 77.00, a price-to-earnings-growth ratio of 5.85 and a beta of 1.55. The firm's 50 day moving average price is $532.72 and its 200-day moving average price is $532.36. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.